Colchicine in High-risk Patients with Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3): Rationale and design of a multicenter randomized placebo-controlled trial

Background: Anti-inflammatory therapy using colchicine has reduced recurrent vascular events in patients with coronary heart disease. Design: Colchicine in High-risk Patients with Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3) is a randomized, double-blind, placebo-c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of stroke 2023-08, Vol.18 (7), p.873-878
Hauptverfasser: Wang, Yongjun, Li, Jiejie, Johnston, S Claiborne, Hankey, Graeme J, Easton, J Donald, Meng, Xia, Shi, Fu-Dong, Wang, Yilong, Zhao, Xingquan, Li, Zixiao, Liu, Liping, Gu, Hongqiu, Jiang, Yong, Wang, Anxin, Pan, Yuesong, Jing, Jing, Niu, Siying, Li, Hao
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!